Zosano Pharma Corp (ZSAN.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Zosano Appoints Steven Elms To Board Of Directors
- BRIEF-Zosano Pharma Q1 Loss Per Share $4.16
- BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study
- BRIEF-Zosano Announces Pricing Of 10 Mln Common Shares At $5 per Share
- BRIEF-Zosano Pharma Corp Files For Offering 10 Mln Shares Of Co's Common Stock